Skip to main content
Back to AI Intelligence Briefing
Clinical AIAugust 18, 2026Source: Journal of Medical Internet Research

Therapeutic Interaction Features of AI Chatbots in Depression: A Systematic Review of Clinical Effectiveness and Design

A JMIR systematic review synthesizes clinical trials of AI-driven chatbots for depression, finding small-to-moderate symptom improvements versus controls that lose statistical significance under more conservative analysis. The paper concludes that while chatbots are promising and often acceptable to users, heterogeneous study designs and limited data mean their clinical value and best-practice design features remain uncertain.

LOG Standards provides this short context and directs readers to the named publisher for the complete report. The source article remains the authoritative account of the underlying reporting.
Read Full Article

About LOG Standards

LOG Standards provides an independent accreditation signal for AI models used in healthcare, helping hospitals, care networks, and AI companies bring clinical AI readiness and governance into clearer conversations.

Our AI Intelligence Briefing tracks the latest developments in AI safety, AI in medicine, mental health AI, clinical AI governance, and regulatory policy — keeping healthcare stakeholders informed about the rapidly evolving AI landscape.